Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Lien Van de Voorde"'
Autor:
Gil Awada, Daphne Serruys, Julia Katharina Schwarze, Lien Van De Voorde, Johnny Duerinck, Bart Neyns
Publikováno v:
Case Reports in Oncology, Vol 13, Iss 2, Pp 1031-1036 (2020)
Patients with neurofibromatosis type 1 (NF1) have an increased lifetime risk for the development of nervous system tumors, including high-grade gliomas (glioblastoma). NF1 is associated with the loss of expression of neurofibromin 1 (NF1 gene product
Externí odkaz:
https://doaj.org/article/2d65106290cf4a539ab6a933d9f94383
Publikováno v:
Case Reports in Hematology, Vol 2014 (2014)
Chylothorax is caused by disruption or obstruction of the thoracic duct or its tributaries that results in the leakage of chyle into the pleural space. A number of interventions have been used to treat chylothorax including the treatment of the under
Externí odkaz:
https://doaj.org/article/b6fb5ce8a16e4b1c90dd5ad8a0fd1d42
Autor:
Lien Van De Voorde, Daphne Serruys, Bart Neyns, Johnny Duerinck, Gil Awada, Julia Katharina Schwarze
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 13, Iss 2, Pp 1031-1036 (2020)
Case Reports in Oncology, Vol 13, Iss 2, Pp 1031-1036 (2020)
Patients with neurofibromatosis type 1 (NF1) have an increased lifetime risk for the development of nervous system tumors, including high-grade gliomas (glioblastoma). NF1 is associated with the loss of expression of neurofibromin 1 (NF1 gene product
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::369c23b29d66fa682e95f7206c99aea2
http://europepmc.org/articles/PMC7548872
http://europepmc.org/articles/PMC7548872
Autor:
Vérane Achard, Maud Jaccard, Frederik Vanhoutte, Shankar Siva, Reino Heikkilä, Piet Dirix, Nick Liefhooghe, François-Xavier Otte, Alfonso Gomez-Iturriaga, Charlien Berghen, Mohamed Shelan, Antonio Conde-Moreno, Fernando López Campos, Alexandros Papachristofilou, Matthias Guckenberger, Sabine Meersschout, Paul Martin Putora, Daniel Zwahlen, Felipe Couñago, Marta Scorsetti, Clara Eito, Marta Barrado, Almudena Zapatero, Paolo Muto, Lien Van De Voorde, Giorgio Lamanna, Nikolaos Koutsouvelis, Giovanna Dipasquale, Piet Ost, Thomas Zilli
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Achard, Vérane; Jaccard, Maud; Vanhoutte, Frederik; Siva, Shankar; Heikkilä, Reino; Dirix, Piet; Liefhooghe, Nick; Otte, François-Xavier; Gomez-Iturriaga, Alfonso; Berghen, Charlien; Shelan, Mohamed; Conde-Moreno, Antonio; Campos, Fernando López; Papachristofilou, Alexandros; Guckenberger, Matthias; Meersschout, Sabine; Putora, Paul Martin; Zwahlen, Daniel; Couñago, Felipe; Scorsetti, Marta; ... (2022). Oligorecurrent nodal prostate cancer: radiotherapy quality assurance of the randomized PEACE V-STORM phase II trial. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 172, pp. 1-9. Elsevier Scientific Publ. Ireland 10.1016/j.radonc.2022.04.020
ABACUS. Repositorio de Producción Científica
Universidad Europea (UEM)
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Achard, Vérane; Jaccard, Maud; Vanhoutte, Frederik; Siva, Shankar; Heikkilä, Reino; Dirix, Piet; Liefhooghe, Nick; Otte, François-Xavier; Gomez-Iturriaga, Alfonso; Berghen, Charlien; Shelan, Mohamed; Conde-Moreno, Antonio; Campos, Fernando López; Papachristofilou, Alexandros; Guckenberger, Matthias; Meersschout, Sabine; Putora, Paul Martin; Zwahlen, Daniel; Couñago, Felipe; Scorsetti, Marta; ... (2022). Oligorecurrent nodal prostate cancer: radiotherapy quality assurance of the randomized PEACE V-STORM phase II trial. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 172, pp. 1-9. Elsevier Scientific Publ. Ireland 10.1016/j.radonc.2022.04.020
ABACUS. Repositorio de Producción Científica
Universidad Europea (UEM)
Purpose: Aim of this study is to report the results of the radiotherapy quality assurance program of the PEACE V-STORM randomized phase II trial for pelvic nodal oligorecurrent prostate cancer (PCa). Material and methods: A benchmark case (BC) consis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9819708392864c8cad4057fb6350b7a8
https://pubmed.ncbi.nlm.nih.gov/35476942
https://pubmed.ncbi.nlm.nih.gov/35476942
Autor:
Thomas Zilli, F. Vanhoutte, Fernando López Campos, Dries Reynders, Maud Jaccard, Antonio J. Conde-Moreno, Almudena Zapatero, C. Mercier, An Spiessens, Kristian Thon, Karin Stellamans, Marta Scorsetti, Matthias Guckenberger, Isabelle Semac, Wouter Everaerts, Alexandros Papachristofilou, Filip Ameye, Els Goetghebeur, Vérane Achard, Piet Ost, Felipe Couñago, Reino Heikkilä, Lien Van De Voorde, François Otte, Shankar Siva, Piet Dirix, N. Liefhooghe, Mohamed Shelan, Daniel Moon, Alfonso Gomez-Iturriaga
Publikováno v:
European Urology Focus
Optimal local treatment for nodal oligorecurrent prostate cancer is unknown. The randomized phase 2 PEACE V-STORM trial will explore the best treatment approach in this setting. Early results on the acute toxicity profile are projected to be publishe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd245caf4f5f39e1b27e154df587a2d5
Autor:
Peter Vandenabeele, Lien Van de Voorde, Bart Vekemans, Jolien Van Pevenage, Melissa Vandevijvere, Laszlo Vincze, Joost Caen, Piet Van Espen
Publikováno v:
Spectrochimica Acta Part B: Atomic Spectroscopy. 184:106251
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::349e3fed07e12ee2c350bc59ac8e5897
https://doi.org/10.1016/j.sab.2021.106251
https://doi.org/10.1016/j.sab.2021.106251
Autor:
Felix M. Mottaghy, Linda Spiegelberg, Ludwig Dubois, Cristina Mitea, Jurgen Peerlings, Philippe Lambin, Sebastian Sandeleanu, Lien Van De Voorde, Ala Yaromina, Ruben T. H. M. Larue
Publikováno v:
Methods. 130:51-62
Purpose: In this systematic review, the existing evidence of available hypoxia-associated molecular response biomarkers in esophageal cancer (EC) patients is summarized and set into the context of the role of hypoxia in the prediction of esophageal c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe283c9732d8a98c1c94f874ce49c82f
https://doi.org/10.1016/j.ymeth.2017.07.002
https://doi.org/10.1016/j.ymeth.2017.07.002
Autor:
Ruben T. H. M. Larue, Janna E. van Timmeren, Maaike Berbee, Wouter van Elmpt, Lien Van De Voorde, Philippe Lambin, Meindert N. Sosef, Wendy M. J. Schreurs, Ralph T.H. Leijenaar
Publikováno v:
Radiotherapy and Oncology, 125(1), 147-153. Elsevier Ireland Ltd
Background and purpose: Quantitative tissue characteristics derived from medical images, also called radiomics, contain valuable prognostic information in several tumour-sites. The large number of features available increases the risk of overfitting.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a26a024afc068300a39bf8ddb684bf5
https://doi.org/10.1016/j.radonc.2017.07.023
https://doi.org/10.1016/j.radonc.2017.07.023
Autor:
Patricia J.A.M. Brouwers, Erik Roelofs, Kim M. Smits, Jurgen Peerlings, Johan van Soest, Timo M. Deist, Daniëlle B.P. Eekers, Marike W. van Gisbergen, Aniek J.G. Even, Janita E. van Timmeren, Sara Carvalho, Bart Reymen, Maaike Berbee, Ben G. L. Vanneste, Ludwig Dubois, Evert J. Van Limbergen, Evelyn E.C. de Jong, Arthur Jochems, Kranthi M. Panth, Ruben T. H. M. Larue, Liesbeth J. Boersma, Bram Ramaekers, Inge Compter, Lien Van De Voorde, Cary Oberije, Wouter van Elmpt, Ralph T.H. Leijenaar, Nicolle H. Rekers, Adriana Berlanga, Jonathan A. Lal, Frank J. P. Hoebers, Andre Dekker, Jaap D. Zindler, Sean Walsh, M. Jacobs, Philippe Lambin, Catharina M.L. Zegers, Ala Yaromina, Tim Lustberg
Publikováno v:
Advanced Drug Delivery Reviews
A paradigm shift from current population based medicine to personalized and participative medicine is underway. This transition is being supported by the development of clinical decision support systems based on prediction models of treatment outcome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::179059e19e231424ede772bc310d293a
https://doi.org/10.1016/j.addr.2016.01.006
https://doi.org/10.1016/j.addr.2016.01.006
Autor:
Michael Pinkawa, Ben G. L. Vanneste, Philippe Lambin, Emile N. van Lin, Lien Van De Voorde, Aswin L. Hoffmann
Publikováno v:
Radiotherapy and oncology 121(1), 118-123 (2016). doi:10.1016/j.radonc.2016.08.026
Radiotherapy and Oncology, 121(1), 118-123. Elsevier Ireland Ltd
Radiotherapy and Oncology, 121(1), 118-123. Elsevier Ireland Ltd
Radiotherapy and oncology 121(1), 118-123 (2016). doi:10.1016/j.radonc.2016.08.026
Published by Elsevier Science, Amsterdam [u.a.]
Published by Elsevier Science, Amsterdam [u.a.]
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48e3d99e224403ea6229a4987260c8ea
https://doi.org/10.1016/j.radonc.2016.08.026
https://doi.org/10.1016/j.radonc.2016.08.026